Suppr超能文献

大麻使用对突显归因的影响:系统评价。

The effects of cannabis use on salience attribution: a systematic review.

机构信息

Department of Psychosis Studies,Institute of Psychiatry, Psychology & Neuroscience,King's College London,London,UK.

出版信息

Acta Neuropsychiatr. 2018 Feb;30(1):43-57. doi: 10.1017/neu.2016.58. Epub 2016 Nov 21.

Abstract

OBJECTIVE

The relationship between cannabis use and the onset of psychosis is well established. Aberrant salience processing is widely thought to underpin many of these symptoms. Literature explicitly investigating the relationship between aberrant salience processing and cannabis use is scarce; with those few studies finding that acute tetrahydrocannabinol (THC) administration (the main psychoactive component of cannabis) can result in abnormal salience processing in healthy cohorts, mirroring that observed in psychosis. Nevertheless, the extent of and mechanisms through which cannabis has a modulatory effect on aberrant salience, following both acute and chronic use, remain unclear.

METHODS

Here, we systematically review recent findings on the effects of cannabis use - either through acute THC administration or in chronic users - on brain regions associated with salience processing (through functional MRI data); and performance in cognitive tasks that could be used as either direct or indirect measures of salience processing. We identified 13 studies either directly or indirectly exploring salience processing. Three types of salience were identified and discussed - incentive/motivational, emotional/affective, and attentional salience.

RESULTS

The results demonstrated an impairment of immediate salience processing, following acute THC administration. Amongst the long-term cannabis users, normal salience performance appeared to be underpinned by abnormal neural processes.

CONCLUSIONS

Overall, the lack of research specifically exploring the effects of cannabis use on salience processing, weaken any conclusions drawn. Additional research explicitly focussed on salience processing and cannabis use is required to advance our understanding of the neurocognitive mechanisms underlying the association between cannabis use and development of psychosis.

摘要

目的

大麻使用与精神病发病之间的关系已得到充分证实。异常突显处理被广泛认为是这些症状的基础。专门研究异常突显处理与大麻使用之间关系的文献很少;少数研究发现,急性四氢大麻酚(THC)给药(大麻的主要精神活性成分)可导致健康队列中异常突显处理,与精神病中观察到的情况相似。然而,大麻在急性和慢性使用后对异常突显的调节作用的程度和机制仍不清楚。

方法

在这里,我们系统地回顾了最近关于大麻使用(通过急性 THC 给药或慢性使用者)对与突显处理相关的大脑区域的影响的研究结果(通过功能磁共振成像数据);以及在认知任务中的表现,这些任务可以作为突显处理的直接或间接测量。我们确定了 13 项直接或间接地探索突显处理的研究。确定并讨论了三种类型的突显处理 - 激励/动机、情感/情感和注意力突显处理。

结果

结果表明,急性 THC 给药后,即时突显处理受损。在长期大麻使用者中,正常突显处理似乎是由异常的神经过程支撑的。

结论

总体而言,缺乏专门研究大麻使用对突显处理影响的研究,削弱了得出的任何结论。需要进行更多专门研究突显处理和大麻使用的研究,以深入了解大麻使用与精神病发病之间关联的神经认知机制。

相似文献

1
The effects of cannabis use on salience attribution: a systematic review.
Acta Neuropsychiatr. 2018 Feb;30(1):43-57. doi: 10.1017/neu.2016.58. Epub 2016 Nov 21.
2
A systematic review of neuroimaging and acute cannabis exposure in age-of-risk for psychosis.
Transl Psychiatry. 2021 Apr 13;11(1):217. doi: 10.1038/s41398-021-01295-w.
3
Interventions targeted at women to encourage the uptake of cervical screening.
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Sertindole for schizophrenia.
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
6
Home treatment for mental health problems: a systematic review.
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
7
The "Next Day" Effects of Cannabis Use: A Systematic Review.
Cannabis Cannabinoid Res. 2023 Feb;8(1):92-114. doi: 10.1089/can.2022.0185. Epub 2022 Dec 6.
8
Cognitive behavioural therapy (group) for schizophrenia.
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD009608. doi: 10.1002/14651858.CD009608.pub2.
9
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
Eur J Cancer. 2007 Jan;43(2):258-70. doi: 10.1016/j.ejca.2006.10.014. Epub 2006 Dec 19.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

引用本文的文献

2
Acute effects of different types of cannabis on young adult and adolescent resting-state brain networks.
Neuropsychopharmacology. 2024 Sep;49(10):1640-1651. doi: 10.1038/s41386-024-01891-6. Epub 2024 May 28.
3
Overshadowing and salience attribution in relation to cannabis use.
Schizophr Res Cogn. 2024 May 10;37:100315. doi: 10.1016/j.scog.2024.100315. eCollection 2024 Sep.
4
Aberrant salience in cannabis-induced psychosis: a comparative study.
Front Psychiatry. 2024 Jan 8;14:1343884. doi: 10.3389/fpsyt.2023.1343884. eCollection 2023.
5
Impact of prenatal cannabis exposure on functional connectivity of the salience network in children.
J Neurosci Res. 2023 Jan;101(1):162-171. doi: 10.1002/jnr.25136. Epub 2022 Oct 13.
6
Latent inhibition, aberrant salience, and schizotypy traits in cannabis users.
Schizophr Res Cogn. 2022 Jan 5;28:100235. doi: 10.1016/j.scog.2021.100235. eCollection 2022 Jun.
7
Cannabis Use, Schizotypy and Kamin Blocking Performance.
Front Psychiatry. 2021 Nov 23;12:633476. doi: 10.3389/fpsyt.2021.633476. eCollection 2021.
8
Understanding the genetics and neurobiological pathways behind addiction (Review).
Exp Ther Med. 2021 May;21(5):544. doi: 10.3892/etm.2021.9976. Epub 2021 Mar 23.
10
Cannabinoids, reward processing, and psychosis.
Psychopharmacology (Berl). 2022 May;239(5):1157-1177. doi: 10.1007/s00213-021-05801-2. Epub 2021 Mar 1.

本文引用的文献

2
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study.
Lancet Psychiatry. 2016 Oct;3(10):947-953. doi: 10.1016/S2215-0366(16)30188-2. Epub 2016 Aug 23.
4
Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis.
Lancet Psychiatry. 2016 Mar;3(3):215-25. doi: 10.1016/S2215-0366(15)00363-6. Epub 2016 Jan 15.
5
Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids.
Psychol Med. 2016 Jan;46(1):27-45. doi: 10.1017/S0033291715001786. Epub 2015 Sep 15.
6
Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.
Lancet Psychiatry. 2015 Mar;2(3):233-8. doi: 10.1016/S2215-0366(14)00117-5. Epub 2015 Feb 25.
8
Marijuana's acute effects on cognitive bias for affective and marijuana cues.
Exp Clin Psychopharmacol. 2015 Oct;23(5):339-50. doi: 10.1037/pha0000030. Epub 2015 Jul 13.
9
Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date.
Eur Neuropsychopharmacol. 2015 Aug;25(8):1201-24. doi: 10.1016/j.euroneuro.2015.03.011. Epub 2015 Mar 30.
10
Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis.
Eur Neuropsychopharmacol. 2015 Jan;25(1):26-37. doi: 10.1016/j.euroneuro.2014.11.018. Epub 2014 Dec 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验